MIBRAR® for Coxarthrosis — Treatment Without Joint Replacement

Coxarthrosis is a degenerative disease of the hip joint that leads to cartilage destruction, pain, and limited mobility. In advanced stages, standard medicine offers the only solution — joint replacement (arthroplasty). MIBRAR® technology provides an alternative — regeneration of your own joint.

Coxarthrosis: Why the Hip Joint Deteriorates

The hip joint is the largest and most loaded joint in the body. The cartilage of the femoral head is under constant pressure during walking, running, and climbing stairs. In coxarthrosis, the cartilage thins, the joint deforms, and osteophytes develop.

Causes of coxarthrosis:

• Age-related wear — the most common cause after age 50
• Dysplasia — congenital joint development disorder
• Avascular necrosis — disrupted blood supply to the femoral head
• Injuries — fractures, dislocations
• Inflammatory diseases — rheumatoid arthritis

How MIBRAR® Restores the Hip Joint

The ARK® concentrate from the patient's own stem cells and growth factors is injected directly into the hip joint under ultrasound guidance:

• Stem cells differentiate into chondrocytes — cartilage cells
• Growth factors stimulate formation of new cartilage matrix
• Anti-inflammatory cytokines reduce synovitis
• Blood supply to the subchondral bone improves

Indications and Stages

MIBRAR® is effective for coxarthrosis stages 1–3, as well as for:

• Avascular necrosis of the femoral head
• Hip impingement syndrome
• Labral tear of the hip joint
• Post-traumatic arthrosis
• Recurrence after previous interventions

MIBRAR® vs Hip Replacement

Results

• Pain reduction — from the first days
• Improved mobility — 2–4 weeks
• Cartilage layer restoration on MRI — 3–6 months
• Overall improvement up to 85% — by 8–16 weeks

Cost of Coxarthrosis Treatment with MIBRAR®